The role of enzalutamide-induced hyperactive Jak2-Stat5 feed-forward signaling loop on enzalutamide-resistant prostate cancer growth and as a therapeutic target for second-line treatment.
Vindhya Udhane(Medical College of Wisconsin), Marja T. Nevalainen(Thomas Jefferson University), Andrew Erickson(University of Helsinki), Kenneth Jacobsohn(Medical College of Wisconsin), Tuomas Mirtti(University of Helsinki), Deepak Kilari(Medical College of Wisconsin), Cristina Maranto(Istituto di Biomedicina e di Immunologia Molecolare Alberto Monroy), Savita Devi(Cedars-Sinai Medical Center), Kenneth A. Iczkowski(University of California, Davis), William A. See(Medical College of Wisconsin), David T. Hoang(Thomas Jefferson University)
Cited by 2
Related Papers
Classification of renal cell carcinoma
|Cancer|1997|878
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
|The American Journal of Surgical Pathology|2020|705
Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study
|The Lancet Oncology|2020|631
Cell-Free DNA in Human Blood Plasma
|Pancreas|1998|381
Bacteriophages show promise as antimicrobial agents
|Journal of Infection|1998|319